Artificial intelligence (AI) continues to revolutionize the pharmaceutical industry by accelerating drug discovery and development. In 2024, companies like Insilico Medicine and Atomwise have been instrumental in using AI algorithms to shorten drug discovery timelines. AI analyzes vast datasets to identify new drug targets, helping researchers focus on the most promising options
Despite its potential, applying AI in pharma requires careful regulation, particularly when AI systems interact with patient data. The pharmaceutical industry is exploring how to balance innovation with safety, aiming to maximize the potential of AI while ensuring regulatory compliance. This approach promises to streamline the research process and improve patient outcomes
.